https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/dubowitz-neuromuscular-centre-confirmed-centre-paediatric-clinical-and-research-excellence/
Dubowitz Neuromuscular Centre confirmed as Centre of Paediatric Clinical and Research Excellence
22 Mar 2016, 3:37 p.m.
The Dubowitz Neuromuscular Centre has been confirmed as a Centre of Paediatric Clinical and Research Excellence by Muscular Dystrophy UK. The centre, based at Great Ormond Street Hospital and the UCL Institute of Child Health (ICH), is one of only ten Centres of Excellence and is the sole Paediatric Centre of Clinical and Research Excellence. This award recognises centres with outstanding levels of specialist care for people living with muscle wasting conditions.
The Dubowitz Neuromuscular Centre is a leading clinical- and research centre specialising in neuromuscular disorders affecting children. The centre provides clinical assessments, diagnostic services, and advice on treatment and rehabilitation alongside clinical trials and basic research focusing on causes of neuromuscular diseases in childhood and identifying new therapeutic interventions. The status was awarded following a national audit carried out by Muscular Dystrophy UK, aimed at ensuring that high-quality care is provided to patients with muscle-wasting conditions.
Great Ormond Street BRC Theme Lead, Professor Francesco Muntoni, is Head of the Dubowitz Neuromuscular Centre, and also leads the Novel Therapies for Translation in Childhood Diseases and the Developmental Neuroscience Programme at the ICH. He is co-director of the MRC Centre for Neuromuscular Diseases at UCL.
New study finds that nasal cells protect against Covid-19 in children
New research shows that children are less likely than adults to develop severe COVID because cells in their nose are better at fighting off the virus.
New plan announced to get more children access to gene therapy treatments
Great Ormond Street Hospital (GOSH) has announced plans to revolutionise how children living with a rare disease can gain access to life-changing treatments.
First-of-its-kind study into the Ketogenic diet
A ketogenic diet, which is low in carbohydrates and high in fat, shows promise as an alternative treatment option for infants with drug-resistant epilepsy.
Raising awareness on Rare Disease Day
To celebrate Rare Disease Day we invited patients and their families to try out 13 different hands-on and interactive fun and educational science and research activities for children and adults.